A Case of Refractory Eosinophilic Gastrointestinal Disease Successfully Treated With Dupilumab

Casey Arnold; Jeptha Johnson; Nieka Harris; Brett Sadowski; Taylor Banks; Allison Bush

doi:10.14309/crj.0000000000001187

A Case of Refractory Eosinophilic Gastrointestinal Disease Successfully Treated With Dupilumab

Casey Arnold, Jeptha Johnson, Nieka Harris, Brett Sadowski, Taylor Banks, Allison Bush

Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Eosinophilic infiltration of the gastrointestinal (GI) tract beyond the esophagus is a rare condition in adults with limited data on treatment. Current treatments with steroids and diet modifications have shown benefit, but when these treatments fall short, there is little research-driven guidance for further recommendations. We present a case of eosinophilic GI disease with extensive involvement of the GI tract successfully treated with dupilumab after failure of traditional treatment occurred.

Original language	English
Pages (from-to)	e01187
Journal	ACG case reports journal
Volume	10
Issue number	11
DOIs	https://doi.org/10.14309/crj.0000000000001187
State	Published - Nov 2023

Access to Document

10.14309/crj.0000000000001187

Cite this

@article{065d9f6920d9434aa2b39df4ec3e7a1f,

title = "A Case of Refractory Eosinophilic Gastrointestinal Disease Successfully Treated With Dupilumab",

abstract = "Eosinophilic infiltration of the gastrointestinal (GI) tract beyond the esophagus is a rare condition in adults with limited data on treatment. Current treatments with steroids and diet modifications have shown benefit, but when these treatments fall short, there is little research-driven guidance for further recommendations. We present a case of eosinophilic GI disease with extensive involvement of the GI tract successfully treated with dupilumab after failure of traditional treatment occurred.",

author = "Casey Arnold and Jeptha Johnson and Nieka Harris and Brett Sadowski and Taylor Banks and Allison Bush",

note = "Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.",

year = "2023",

month = nov,

doi = "10.14309/crj.0000000000001187",

language = "English",

volume = "10",

pages = "e01187",

journal = "ACG case reports journal",

issn = "2326-3253",

number = "11",

}

TY - JOUR

T1 - A Case of Refractory Eosinophilic Gastrointestinal Disease Successfully Treated With Dupilumab

AU - Arnold, Casey

AU - Johnson, Jeptha

AU - Harris, Nieka

AU - Sadowski, Brett

AU - Banks, Taylor

AU - Bush, Allison

N1 - Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.

PY - 2023/11

Y1 - 2023/11

N2 - Eosinophilic infiltration of the gastrointestinal (GI) tract beyond the esophagus is a rare condition in adults with limited data on treatment. Current treatments with steroids and diet modifications have shown benefit, but when these treatments fall short, there is little research-driven guidance for further recommendations. We present a case of eosinophilic GI disease with extensive involvement of the GI tract successfully treated with dupilumab after failure of traditional treatment occurred.

AB - Eosinophilic infiltration of the gastrointestinal (GI) tract beyond the esophagus is a rare condition in adults with limited data on treatment. Current treatments with steroids and diet modifications have shown benefit, but when these treatments fall short, there is little research-driven guidance for further recommendations. We present a case of eosinophilic GI disease with extensive involvement of the GI tract successfully treated with dupilumab after failure of traditional treatment occurred.

U2 - 10.14309/crj.0000000000001187

DO - 10.14309/crj.0000000000001187

M3 - Article

C2 - 37941581

SN - 2326-3253

VL - 10

SP - e01187

JO - ACG case reports journal

JF - ACG case reports journal

IS - 11

ER -